-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test is an affordable, accessible blood test that detects cancer in dogs.
-
- Our Pipeline Development
-
Nu.Q® Cancer
We are developing a range of blood-based assays with potential applications beyond cancer detection.
-
Capture-Seq™
We have developed Capture-Seq™, a novel liquid biopsy method designed to isolate and analyze pure circulating tumor-derived DNA (ctDNA) from blood samples.
We’re here to help.
Contact our team and we will be back in touch as soon as possible
-
Close
Technical Support
For technical queries about using our Nu.Q® products.
-
Close
Complaint Reporting
For complaints, comments and suggestions, contact our Quality Assurance Team.
-
Close
Sales and Product Inquiries
To find out more about proprietary Nu.Q® product portfolio.
General Inquiries
"*" indicates required fields
Technical Support
"*" indicates required fields
Complaints Form
"*" indicates required fields
Sales and Product Inquiries
We are a multinational epigenetics company with sites in America, Europe and Asia.
Belgium
